NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.00 Cr | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr |
What is the latest Contingent Liabilities ratio of NATCO PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.00 Cr |
| Mar2024 | ₹0.40 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹8.00 Cr |
| Mar2021 | ₹1.20 Cr |
How is Contingent Liabilities of NATCO PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.00 Cr | 650.00 | |
| Mar2024 | ₹0.40 Cr | -97.26 | |
| Mar2023 | ₹15 Cr | 82.50 | |
| Mar2022 | ₹8.00 Cr | 566.67 | |
| Mar2021 | ₹1.20 Cr | - | |
Compare Contingent Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,700.5 Cr | 10.7% | 18.3% | 21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 10.7% |
18.3% |
21.8% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses